Lichen China Limited (LICN) Income Statement
LICN 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsLICN revenue and net income
Where LICN's revenue goes
2025Each bar shows an amount and its share of revenue. LICN kept −89.6% of revenue as net income.
LICN profit margins
LICN growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −40.9% | −10.2% | −4.4% | +10.2% |
| Gross profit | −64.4% | −23.2% | −13.5% | +4.0% |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
LICN quarterly EPS vs estimates
Lichen China beat the analyst EPS estimate in 2 of the last 4 quarters.
LICN income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $24.5M | $41.5M | $39.8M | $33.8M | $34.3M | $30.7M | $31.6M | $25.6M | $20.8M | $14.8M |
| Cost of revenue | $15.4M | $15.8M | $15.4M | $13.6M | $13.8M | $11.8M | $12.3M | $7.3M | $5.6M | $4.2M |
| Gross profit | $9.1M | $25.7M | $24.3M | $20.2M | $20.5M | $18.8M | $19.3M | $18.2M | $15.2M | $10.5M |
| Research & development | — | $1.4M | $1.2M | $1.1M | $1.1M | $930,000 | — | $620,133 | $397,377 | $396,651 |
| Sales, general & admin | $23.5M | $17.7M | $8.9M | $7.4M | $7.2M | $8.5M | $9.6M | — | — | — |
| Total operating expenses | $23.5M | $30.2M | $12.1M | $9.5M | $9.2M | $10.0M | $9.6M | $8.9M | $6.5M | $5.1M |
| Operating income | −$14.4M | −$4.6M | $12.3M | $10.6M | $11.3M | $8.8M | $9.7M | $9.3M | $8.6M | $5.4M |
| Interest income | $146,000 | $163,000 | $38,000 | $60,000 | $28,000 | $103,000 | — | — | — | — |
| Interest expense | — | — | — | $94,000 | $216,000 | $209,000 | $49,000 | — | — | — |
| Income before taxes | −$21.8M | −$4.2M | $11.6M | $10.7M | $11.5M | $9.0M | $9.7M | $9.4M | $8.7M | $5.4M |
| Income taxes | — | $1.9M | $3.2M | $2.9M | $3.1M | $2.6M | $2.7M | $2.9M | $2.4M | $1.5M |
| Net income | −$22.0M | −$6.1M | $8.3M | $7.8M | $8.5M | $6.4M | $7.1M | $6.5M | $5.8M | $4.0M |
| EBITDA | −$10.3M | −$1.7M | $15.2M | $13.3M | $13.7M | $9.6M | $12.0M | $9.8M | $9.0M | $5.6M |
| EPS (diluted) | −$1.35 | −$14.10 | $62.93 | $0.48 | $0.18 | $0.28 | $0.25 | $0.23 | $0.20 | $0.14 |
| Gross margin | 37.3% | 61.9% | 61.2% | 59.7% | 59.7% | 61.4% | 61.2% | 71.3% | 73.0% | 71.3% |
| Operating margin | −58.8% | −11.0% | 30.8% | 31.5% | 32.9% | 28.7% | 30.8% | 36.4% | 41.5% | 36.5% |
| Net margin | −89.6% | −14.8% | 21.0% | 23.1% | 24.7% | 20.9% | 22.4% | 25.4% | 28.0% | 26.8% |
| Jun '26 | Mar '26 | Jun '25 | Mar '25 | Jun '24 | Mar '24 | Sep '23 | Jun '23 | Mar '23 | Sep '22 | Jun '22 | Mar '22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.3M | $10.3M | $14.3M | $23.4M | $18.1M | $23.8M | $11.9M | $15.9M | $17.7M | $8.8M | $16.1M | $8.1M |
| Cost of revenue | $8.7M | $7.7M | $7.7M | $8.7M | $7.1M | $9.3M | $4.7M | $6.1M | $7.9M | $3.9M | $5.7M | $2.9M |
| Gross profit | $1.5M | $2.5M | $6.6M | $14.7M | $11.0M | $14.5M | $7.2M | $9.8M | $9.8M | $4.9M | $10.4M | $5.2M |
| Research & development | — | — | — | $1.4M | — | $1.2M | $595,000 | — | $1.1M | $530,000 | — | — |
| Sales, general & admin | — | $11.7M | $11.8M | $12.2M | $9.3M | $4.4M | $2.2M | $7.0M | $3.7M | $1.9M | $3.7M | $1.9M |
| Total operating expenses | $10.3M | $11.7M | $11.8M | $21.0M | $9.3M | $5.1M | $2.5M | $7.7M | $5.0M | $2.5M | $4.5M | $2.2M |
| Operating income | −$8.7M | −$9.2M | −$5.2M | −$6.3M | $1.7M | $9.4M | $4.7M | $2.9M | $4.9M | $2.4M | $5.8M | $2.9M |
| Income before taxes | −$11.5M | −$12.7M | −$9.1M | −$5.9M | $1.8M | $9.4M | $4.7M | $2.2M | $4.8M | $2.4M | $5.9M | $3.0M |
| Income taxes | $13,000 | −$88,000 | $88,000 | $948,000 | $1.0M | $2.5M | $1.2M | $796,000 | $1.3M | $655,000 | $1.6M | $807,000 |
| Net income | −$11.5M | −$12.6M | −$9.4M | −$6.9M | $767,000 | $7.0M | $3.5M | $1.4M | $3.5M | $1.7M | $4.3M | $2.2M |
| EBITDA | −$6.0M | −$6.9M | −$3.2M | −$5.0M | $2.1M | $9.6M | $4.8M | $3.4M | $5.4M | $2.7M | $6.0M | $3.0M |
| EPS (diluted) | — | — | −$33.08 | −$34.00 | $5.16 | — | — | — | — | — | $0.32 | — |
| Gross margin | 15.1% | 24.8% | 46.2% | 62.9% | 60.6% | 60.8% | 60.8% | 61.7% | 55.4% | 55.4% | 64.4% | 64.4% |
| Operating margin | −85.0% | −89.3% | −36.8% | −26.7% | 9.4% | 39.5% | 39.5% | 17.9% | 27.6% | 27.6% | 35.7% | 35.7% |
| Net margin | −112.5% | −122.9% | −65.6% | −29.5% | 4.2% | 29.3% | 29.3% | 8.5% | 19.8% | 19.8% | 26.8% | 26.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in LICN's financial statements (latest annual report filed April 28, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
LICN financial results
In fiscal year 2025 (ended December 31, 2025), Lichen China reported revenue of $24.5 million, down 40.9% from the year before. It had a net loss of $22.0 million, a net profit margin of −89.6%. Diluted earnings per share came to −$1.35. Over five years revenue grew at an average rate of −4.4% a year.
See the LICN stock overview for the latest quote and news, or the LICN chart for price history and technical indicators.
LICN income statement FAQ
What is Lichen China's annual revenue?
Lichen China reported total revenue of $24.5 million for fiscal year 2025, which ended on December 31, 2025. That was down 40.9% from $41.5 million the previous year.
Is Lichen China profitable?
No. Lichen China reported a net loss of $22.0 million in fiscal 2025, a net profit margin of −89.6%; its operating margin was −58.8%.
What is Lichen China's gross margin?
Lichen China's gross margin was 37.3% in fiscal 2025: for every $100 of revenue, Lichen China kept $37 after the direct cost of its products and services.
How fast is Lichen China growing?
Revenue grew −4.4% a year on average over the last five fiscal years, from $30.7 million to $24.5 million.
What are Lichen China's earnings per share?
Lichen China earned $-1.35 per diluted share in fiscal 2025, compared with $-14.10 a year earlier.
When does Lichen China's fiscal year end?
Lichen China's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on April 28, 2026.